Alnylam Pharmaceuticals
ALNY
#650
Rank
$27.53 B
Marketcap
$229.39
Share price
-1.13%
Change (1 day)
13.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: $27.53 Billion

As of August 2022 Alnylam Pharmaceuticals has a market cap of $27.53 Billion. This makes Alnylam Pharmaceuticals the world's 650th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2022

End of year Market Cap

Year Market cap Change
2022$27.53 B35.75%
2021$20.28 B34.32%
2020$15.10 B16.87%
2019$12.92 B75.15%
2018$7.37 B-41.45%
2017$12.59 B292.16%
2016$3.21 B-59.89%
2015$8.01 B6.97%
2014$7.48 B82.71%
2013$4.09 B327.85%
2012$0.95 B175.09%
2011$0.34 B-16.59%
2010$0.41 B-43.36%
2009$0.73 B-28.02%
2008$1.02 B-13.62%
2007$1.18 B49.54%
2006$0.79 B207.77%
2005$0.25 B78.85%
2004$0.14 B

End of Day market cap according to different sources

On Aug 11th, 2022 the market cap of Alnylam Pharmaceuticals was reported to be:

$27.53 Billion
by Yahoo Finance
$27.53 Billion
by CompaniesMarketCap
$27.71 Billion
by Nasdaq
$27.51 Billion
by Iex Cloud
$27.84 Billion
by Reuters

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$186.80 B 578.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$108.58 B 294.39%๐Ÿ‡ซ๐Ÿ‡ท France
$68.01 B 147.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.56 B-65.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.02 B-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.92 B-92.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.31 B-55.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$4.82 B-82.46%๐Ÿ‡บ๐Ÿ‡ธ USA